Why is Samsung discontinuing Vascular Load tracking in the US?
Samsung has decided to phase out the Vascular Load monitoring feature on Galaxy Watches sold in the US less than a year after its introduction. The move appears linked to regulatory complexities, likely involving compliance with the Food and Drug Administration (FDA). Without official explanation, many users suspect the feature faced hurdles related to medical device approvals. Unlike in other countries, where Vascular Load remains available, US users will lose direct access to this cardiovascular health tracking tool following the update to Samsung Health 7.0 and One UI 9.
What replaces Vascular Load and how does it work?
To compensate for Vascular Load’s removal, Samsung is introducing a new feature called Blood Pressure Trend, debuting on upcoming Galaxy Watch models. Instead of providing vascular load metrics derived from heart rate variability and blood volume changes, Blood Pressure Trend helps users monitor their blood pressure patterns over time. Crucially, it requires users to pair their watch with a traditional blood pressure cuff for calibration and regular monthly measurements to maintain data accuracy. This feature is primarily intended for wellness tracking rather than medical diagnosis or treatment. Moreover, it will provide users with lifestyle recommendations to encourage healthier habits based on their blood pressure trends.
What should US Galaxy Watch users know about the change?
Current users of the Vascular Load feature in the US should download and save any existing health data before the feature is disabled. The functionality will no longer be accessible via Samsung Health after late July updates. Users should prepare to adapt to the new Blood Pressure Trend system, which although different in approach, continues Samsung's focus on cardiovascular wellness. However, transitioning to Blood Pressure Trend means investing in a compatible blood pressure cuff and periodically calibrating the watch for accurate readings. This adds some complexity compared to the formerly automatic Vascular Load measurement. Samsung’s shift reflects broader challenges tech companies face when balancing innovative health monitoring with regulatory standards, particularly in stringent markets like the US.
Clear takeaway for Galaxy Watch users in the US
Samsung’s removal of Vascular Load from its US Galaxy Watches signals a move to align better with medical regulations, replacing it with a blood pressure tracking feature that emphasizes wellness over clinical diagnosis. While this means losing some automatic cardiovascular metrics, the new approach may offer more reliable data when paired properly with standard cuffs. Users should understand the need to download current Vascular Load data and be prepared for a more hands-on process with the Blood Pressure Trend feature. This change underscores the trade-offs between cutting-edge health tech and regulatory compliance, highlighting how device capabilities can vary regionally. For those deeply invested in uninterrupted vascular health monitoring on smartwatches, exploring alternative devices or platforms might become necessary until features fully stabilize globally.